Nonalcoholic Steatohepatitis (NASH)
Topics
(1/7) > >>
[1] When Will We See Drug Treatments for NASH Fibrosis?
[2] Fatty Liver Disease Is Linked to Higher Liver Cancer Risk
[3] Fatty Liver Disease Highly Prevalent in American Adults
[4] NASH Is the Second Leading Indication for Liver Transplants
[5] More Physical Activity Tied to Lower Fatty Liver Disease Mortality
[6] Egrifta Improves Liver Health in People With HIV
[7] Company Halts Leading NASH Drug but Another Shows Promise
[8] FDA Delays Approval of Ocaliva for Fatty Liver Disease
[9] Fatty Liver Disease Is Less Common but More Severe in Women
Navigation
[0] Up one level
[#] Next page